Obstetrics
Intrapartum management of women on anticoagulation therapy requires planning
Published in Women's Health Weekly, September 11th, 2003
According to a study from England, "women requiring full anticoagulation in pregnancy and labor present their care providers with complex management problems, particularly during the peripartum period. Available guidelines often fail to address the practical issues of balancing the risks of recurrent thrombotic events and hemorrhage during labor. This is especially the case in women at high risk of recurrent thromboembolism, in whom the usually recommended temporary peripartum reduction in the level of anticoagulation may be considered unsafe."
"In order to achieve a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Hormone Replacement Therapy
Greatest risk of heart attack occurs in first year of use for most women - Osteoporosis
Lower-dose ERT prevents bone loss with few adverse effects - Alopecia
Testosterone levels rise in young women with female pattern hair loss - Cervical Cancer
Distant metastases are usually due to recurrent disease - Gynecology
High-intensity physical activity reduces endometrioma risk - Infertility
Antibody against motility inhibiting protein may enhance human fertility - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
